79 related articles for article (PubMed ID: 2369756)
1. [Pharmacokinetics and pharmacodynamics of furosemide in liver cirrhosis].
Tesar V; Kotal P; Petrtýl J; Bukovská J; Kozáková M; Brodanová M; Horký K; Kordac V
Cas Lek Cesk; 1990 May; 129(21):657-64. PubMed ID: 2369756
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
Sanchis Closa A; Lambert C; du Souich P
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
5. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
6. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
Rector WG
Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
[TBL] [Abstract][Full Text] [Related]
7. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
[TBL] [Abstract][Full Text] [Related]
8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
9. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
[TBL] [Abstract][Full Text] [Related]
10. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
11. Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration.
Rector WG
J Lab Clin Med; 1988 Feb; 111(2):166-72. PubMed ID: 3339270
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
13. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
14. Effect of dipyridamole on kidney function in cirrhosis.
Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
[TBL] [Abstract][Full Text] [Related]
15. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
Mansurov KhKh; Dustov AD
Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
Gerbes AL; Gülberg V; Waggershauser T; Holl J; Reiser M
Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
[TBL] [Abstract][Full Text] [Related]
18. Comparative acute effects of diflunisal and indomethacin on renal function in patients with cirrhosis and ascites.
Antillon M; Cominelli F; Reynolds TB; Zipser RD
Am J Gastroenterol; 1989 Feb; 84(2):153-5. PubMed ID: 2916525
[TBL] [Abstract][Full Text] [Related]
19. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and dynamics of furosemide in the newborn piglet.
Miceli JJ; Kramer PA; Chapron DJ; Rosenkrantz TS; Raye JR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1126-32. PubMed ID: 2359020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
